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Background: Hepatitis C virus (HCV) is estimated to infect 200 million individuals in the globe, including
approximately 10 million in Pakistan causing both acute and chronic hepatitis. The standard treatment against HCV
is pegylated interferon therapy in combination with a nucleoside analogue ribavirin. In addition, several herbal
extracts and phytochemicals derivatives are used traditionally in the treatment of liver diseases as well as HCV
infection. The present study determines the inhibitory effect of kaolin minerals compound against hepatitis C virus
in Huh-7 cell lines.
Methods: Huh-7 cell lines were used for the in vitro HCV replication by using HCV positive sera from different
patients with known HCV genotypes and viral titer/load. Total RNA was extracted from these infected cells and was
quantified by real-time polymerase chain reaction (Real-time PCR). The viral titer was compared with the control
samples to determine the anti-HCV activity of kaolin derived compounds. Kaolin is a group of clay minerals, with
the chemical composition Al2 Si2O5 (OH)4.
Results: The results showed promising effectiveness of local kaolin derived anti-HCV compounds by causing 28%
to 77% decrease in the HCV titer, when applied to infected Huh-7 cell lines. This study provides the basis for future
work on these compounds especially to determine the specific pathway and mechanism for inhibitory action in the
replicon systems of viral hepatitis.
Conclusions: Kaolin mineral derivatives show promising inhibitory effects against HCV genotypes 3a and 1a
infection, which suggests its possible use as complementary and alternative medicine for HCV viral infection.
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Hepatitis C virus (HCV) is contributing increasing dis-
ease burden on global healthcare services and nearly 200
million people are infected worldwide by this virus [1,2].
Most of these infections cause chronic hepatitis and lead-
ing to progressive liver disease including cirrhosis, fibrosis
and finally hepatocellular carcinoma (HCC) [3-5]. Fibrosis
and cirrhosis is caused in up to 30% infected patients. It is
estimated that 1-4% of the cirrhotic patients develop HCC
[6-9]. Significant correlation of chronic HCV infection
and HCC has been reported with genotype 3a in Pakistani
population [10].* Correspondence: idreeskhan96@yahoo.com
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reproduction in any medium, provided the orThe current most effective therapy for HCV consists
of pegylated interferon-α (IFN-α), administered once
weekly plus daily oral ribavirin (RBV) for 24 to 48 weeks
[11,12]. This combination therapy is quite successful in
patients with HCV genotype 3 or 2 infection, leading to
sustained virological response (SVR) in about 80-90% of
patients treated. However, in patients infected with HCV
genotype 1 or 4, only about a half of treated individuals
achieve SVR [13,14]. Further, the treatment is often
linked with severe side effects and high expenses. The
HCV RNA level before therapy also effect treatment
outcome in patients with genotype-1 infection. Patients
with low baseline viral loads (e.g., <8 × 105 IU/mL), have
a better chance of SVR [15].
Beside the standard interferon plus ribavirin therapy,
several plants, herb species and their derivatives have alsoThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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active phytochemicals including the polyines, flavonoids, al-
kaloids, thiophenes, terpenoids and proteins have been
identified to possess antiviral activity [17]. Most of these
compounds have overlapping mechanisms of actions. Many
medicinal plants are waiting to be exploited and evaluated
for antiviral applications.
Kaolin is a group of clay minerals, with the chemical
composition Al2 Si2O5(OH)4. It is a layered silicate
mineral with one tetrahedral sheet linked through oxy-
gen atoms to one octahedral sheet of alumina octahe-
dral. It is also known as china clay or white clay.
Mostly, white, brownish and grayish white in colour,
also waxy and dull and contain common impurities
like:Fe, Mg, Na, K,Ti, Ca, H2O [18]. Up to 350 mineral
drugs have been identified and reported with medicinal
value. Nearly 60 of these are still commonly used but
prescribed alone rarely. However, they are usually given in
combination with other components [19,20]. Now a days
Selenium and its derivatives are favourable choice of
complimentary alternative medicine (CAM) for liver dis-
eases like HCV [21].
The main objective of the present study was to evalu-
ated local kaolin mineral derivatives for their anti-HCV
activity in the human hepatoma cell lines infected with
HCV sera of different patients with known viral loads
and genotypes.
Methods
Serum sample collection
Sera from more than 32 patients (12 and 20 samples of
genotype 1a and 3a respectively) chronically infected
with HCV infections was obtained from the molecular
diagnostics facility, Centre for Applied Molecular Biol-
ogy (CAMB), Lahore, Pakistan. The average serum viral
loads of the samples were in the range of 227 × 103 to
925 × 106 IU/mL. All patients were negative for HBsAg.
Informed written consent was obtained from the pa-
tients and the study was approved by the institutional
ethics committee of National Centre of Excellence in
Molecular Biology, Lahore.
Cell lines
The Huh-7 and CHO cell lines were obtained from the
Cell Bank of CEMB, University of the Punjab, Lahore.
Kaolin derivatives
Total two different kaolin derivatives (kaolin minerals)
were obtained in dimethyl sulfoxide (DMSO) as solv-
ent, using modified method described by Alpert in
1984 [22]. The two different silicates minerals were ob-
tained by using different soil from different places.
Mineral derivative “A” as obtained from muddy soil
while “B” was from sandy soil. Finally, these twocompounds were selected for the determination of
anti-HCV activity in vitro using Huh-7 cell lines. The
mineral derivative of Kaolin was basically obtained
from muddy and sandy soil.
Physical properties of the kaolin
Mostly, White,Brownish white, Grayish white, Yellowish
white and in color also Waxy, Dull and Pearly. Visible
crystals extremely rare. Non fluorescent and Transparent
to translucent diaphaneity etc.
Chemical properties of the kaolin
Formula: Al2 Si2O5 (OH)4
Essential Elements: Al, H, O, Si
Common Impurities: Fe, Mg, Na, K, Ti, Ca, H2O
Cell culture
The Huh-7 and Chinese hamster ovary (CHO) cell line
were grown in Dulbecco’s modified eagle medium (DMEM)
supplemented with 100 μg/ml penicillin, 100 μg/ml strepto-
mycin and 10% fetal bovine serum (FBS) (Wisent INC.,
Montreal, Canada) incubated at 37°C with 5% CO2.
They are highly permissive for the initiation of HCV
replication.
Cell splitting and plating
The Huh-7 cell line grown in DMEM supplemented
with appropriate antibiotic, 10% FBS and CO2 was split
and plated for toxicological analysis of kaolin derivatives.
Anti-HCV analysis of kaolin minerals derivatives in
Huh-7 cells
Huh-7 cell line was used for the in vitro HCV replica-
tion as described previously [23,24]. Total RNA was
extracted from the Huh-7 cells infected with HCV
serum using the Purescript RNA Isolation kit (Life
Technologies, USA).
HCV RNA quantitative detection in Huh-7 cells by real
time PCR
HCV REAL-TM Quant SC kit (Sacace Biotechnologies,
Italy) used in Smart Cycler (Cepheid) was used for Real-
Time quantitative assay of HCV RNA in human plasma
following procedure given in the kit protocol.
Results
Toxicity analysis of kaolin derivatives in Huh-7 cells
Toxicity of kaolin derivatives was initially determined
in Huh-7 Cell Lines. These cells were treated with dif-
ferent concentrations of the kaolin derivatives. After
24 hrs, cells were trypsinized and counted through
haemocytometer. The viability of Huh-7 cells was con-
firmed at different concentrations by using trypan blue
exclusion test. The concentration at which more than
Figure 1 Graphical presentation of toxicity analysis of kaolin derivatives A and B in Huh-7 cells treated at different concentrations from
10 - 60 μl. Figure legend text.
Ali et al. BMC Research Notes 2014, 7:247 Page 3 of 5
http://www.biomedcentral.com/1756-0500/7/24770-80 percent of the cells survived was considered as
non-toxic. 1X-PBS was used as a control. Administrations
of up to 40 μl (50 μg/ml) of the local drugs (A and B) were
found non-toxic to the cells (Figure 1).
Antiviral analysis of kaolin derivatives in Huh-7 cell line
Antiviral activity of kaolin minerals derivatives “A and
B” was determined in Huh-7 cells at different concentra-
tions ranging from 10 to 50 μl (at concentration of
50 μg of kaolin derivatives/ml) as shown in the following
Figures 2, 3 and 4. Both the local drugs were found non-
toxic to the liver cells up to the administration of 30 μl
dose. DMSO was used as a negative control while HCV
infected sera was used as a positive control.
Viral titer of genotype 3a in infected Huh-7 cell lines
was decreased up to 70% by using minerals derivatives “A”
and 56% by administration of “B” as compared to the po-
sitive control samples. Similarly, reduction in HCV RNA
of genotype 1a was observed up to 77% and 28% byFigure 2 Antiviral activity of kaolin derivatives A; Infected Huh-7 cells
RNA levels are shown as a percentage relative to the levels of HCV RNA inadministering “A and B” respectively. These results show
that kaolin derivatives “A” is relatively more effective
against genotype 3a and 1a, which suggests its use as com-
plementary and alternative medicine for the treatment of
HCV infection.
Discussion
Currently, there is no antiviral drug completely effective
against HCV infection [25]. The standard treatment
against HCV infection is interferon therapy in combin-
ation with a nucleoside analogue ribavirin [13]. However,
the treatment with pegylated interferon (IFN) plus riba-
virin leads to a sustained virologic response in about
50% of patients [26] and lead to emergence of resistant
quasispecies/strains due to increased drug pressure [27].
For rest of 50% non-respondents, supportive therapy
with non-traditional compounds such as kaolin mineral
obtained from the soil of different sources, which are
suggested to have anti-HCV properties.were treated with 10 to 50 μl concentrations for 24 hours. HCV
cells incubated with control.
Figure 3 Antiviral activity of kaolin derivatives B; Infected Huh-7 cells were treated with 10 to 50 μl concentrations for 24 hours.
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conventional derivatives of kaolin mineral compounds
against HCV in two different cell lines (i.e. Huh-7 &
CHO cell lines). Different solvents such as dimethyl
sulfoxide (DMSO), ethanol, methanol, acetone and
water were used to determine solubility of the com-
pounds. Huh-7 cell lines are important in studying
antiviral activity in vitro as it allows HCV replication
due to its expression of LDL-receptor molecules [28].
HCV genotype 3a and 1a were used for evaluation of
antiviral responses. Viral titer was considered as an in-
dicator of antiviral response. The concentrations of
50 μg/mL to 50 mg/mL with volume of 10-60 μl of
both drugs were used.
Initially, different concentrations of kaolin deriva-
tives “A and B” were analyzed for cytotoxicity in the
Huh-7 and CHO cell lines. Both the compounds were
found non-toxic up to the administration of 30 μl
(50 μg of kaolin derivative/ml). At these concentrationsFigure 4 Antiviral activity of kaolin derivatives A and B; Infected Huhcells did not display any significant cytotoxicity during
regular cell passage and trypan blue counting. Cells
viability was counted by haemocytometer and trypan
blue stain method. The present study provides experi-
mental data of local kaolin derived drugs for clinical
treatment of chronic hepatitis C virus infection.Conclusions
We suggest that there could be excellent therapeutic
agents in kaolin mineral compounds for the treatment
of HCV infections. However, further studies are re-
quired to identify the specific active ingredients by
using various techniques. This study also provides
basis for future work on these compounds especially
minerals derivatives A to determine its mechanism of
action in the replicon systems and clinical trials for the
treatment of the hepatitis C. Moreover, this study will
be helpful to explore the new horizons of the discoveries-7 cells were treated with 30 μl concentrations for 24 hours.
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tory effects against HCV.
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